270.09
Overview
News
Price History
Option Chain
Financials
Why CI Down?
Discussions
Forecast
Stock Split
Dividend History
Cigna Group stock is traded at $270.09, with a volume of 2.22M.
It is down -3.68% in the last 24 hours and down -2.32% over the past month.
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
See More
Previous Close:
$280.41
Open:
$279
24h Volume:
2.22M
Relative Volume:
1.14
Market Cap:
$72.15B
Revenue:
$268.22B
Net Income/Loss:
$6.55B
P/E Ratio:
11.91
EPS:
22.6688
Net Cash Flow:
$7.44B
1W Performance:
-0.42%
1M Performance:
-2.32%
6M Performance:
-8.87%
1Y Performance:
-11.65%
Cigna Group Stock (CI) Company Profile
Name
Cigna Group
Sector
Industry
Phone
(860) 226-6000
Address
900 COTTAGE GROVE ROAD, BLOOMFIELD, CT
Compare CI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
CI
Cigna Group
|
270.09 | 74.90B | 268.22B | 6.55B | 7.44B | 22.67 |
|
UNH
Unitedhealth Group Inc
|
282.70 | 318.53B | 435.16B | 18.37B | 17.37B | 19.16 |
|
CVS
Cvs Health Corp
|
72.00 | 106.47B | 393.94B | 428.00M | 6.29B | 0.3826 |
|
ELV
Elevance Health Inc
|
322.92 | 83.77B | 194.82B | 5.53B | 3.77B | 24.45 |
|
HUM
Humana Inc
|
207.93 | 31.71B | 126.36B | 1.30B | 1.55B | 10.67 |
Cigna Group Stock (CI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-14-25 | Initiated | Goldman | Buy |
| Feb-06-25 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jun-26-24 | Initiated | Piper Sandler | Overweight |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-06-24 | Initiated | Barclays | Overweight |
| Feb-05-24 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-05-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-01-24 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-04-24 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Dec-11-23 | Upgrade | Jefferies | Hold → Buy |
| Aug-18-23 | Downgrade | Edward Jones | Buy → Hold |
| Jun-06-23 | Upgrade | BofA Securities | Neutral → Buy |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Neutral |
| Apr-05-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Jan-03-23 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Nov-23-22 | Resumed | Morgan Stanley | Overweight |
| Nov-21-22 | Downgrade | Raymond James | Strong Buy → Outperform |
| Jul-14-22 | Downgrade | Jefferies | Buy → Hold |
| Jun-22-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-27-22 | Resumed | Bernstein | Mkt Perform |
| May-26-22 | Upgrade | BofA Securities | Underperform → Neutral |
| May-16-22 | Upgrade | JP Morgan | Neutral → Overweight |
| May-09-22 | Upgrade | Cowen | Market Perform → Outperform |
| Feb-07-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Feb-04-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-06-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-21-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Dec-14-21 | Initiated | Goldman | Neutral |
| Nov-17-21 | Initiated | Seaport Research Partners | Buy |
| Sep-27-21 | Initiated | SVB Leerink | Mkt Perform |
| Sep-10-21 | Downgrade | BofA Securities | Buy → Underperform |
| Sep-10-21 | Initiated | Cowen | Market Perform |
| Aug-06-21 | Reiterated | BofA Securities | Buy |
| Aug-06-21 | Reiterated | Citigroup | Buy |
| Aug-06-21 | Reiterated | Deutsche Bank | Buy |
| Aug-06-21 | Reiterated | Jefferies | Buy |
| Aug-06-21 | Reiterated | Mizuho | Buy |
| Aug-06-21 | Reiterated | Oppenheimer | Outperform |
| Aug-06-21 | Reiterated | Truist | Buy |
| May-19-21 | Initiated | Wells Fargo | Equal Weight |
| Jul-01-20 | Initiated | SVB Leerink | Mkt Perform |
| May-04-20 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Mar-24-20 | Upgrade | Raymond James | Outperform → Strong Buy |
| Dec-11-19 | Downgrade | Wells Fargo | Market Perform → Underperform |
| Oct-18-19 | Initiated | Mizuho | Buy |
| Sep-30-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Aug-06-19 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Apr-23-19 | Initiated | UBS | Buy |
| Jan-14-19 | Initiated | Stephens | Overweight |
| Dec-24-18 | Initiated | Edward Jones | Buy |
| Mar-13-18 | Initiated | Bernstein | Mkt Perform |
| Mar-08-18 | Initiated | Barclays | Overweight |
| Jan-03-18 | Initiated | Goldman | Neutral |
| Nov-03-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-22-17 | Reiterated | RBC Capital Mkts | Outperform |
| Jun-12-17 | Initiated | Credit Suisse | Outperform |
| Jun-07-17 | Initiated | Morgan Stanley | Overweight |
| May-08-17 | Reiterated | RBC Capital Mkts | Outperform |
| Apr-05-17 | Initiated | Deutsche Bank | Buy |
View All
Cigna Group Stock (CI) Latest News
Insurance moves: CRC, Integrity and Pan-American Life Insurance - Insurance Business
Insurance moves at CRC, Integrity and Pan-American Life Insurance - Insurance Business
Celltrion drives record US Zymfentra prescriptions with broader coverageCHOSUNBIZ - Chosunbiz
Healthcare: Managed Care Stocks Plunge Following Almost-Flat Medicare Rate Proposal - Morningstar
The Cigna Group (CI) Shares Gap Down to $271.89 on Jan 27 - GuruFocus
Cigna Group $CI Shares Bought by Maj Invest Holding A S - MarketBeat
The Cigna Group (NYSE:CI) Stock Signal: Is the FTC Settlement Pause for Express Scripts a Buying Opportunity? - DailyForex
Cigna Group $CI Shares Sold by Vanguard Personalized Indexing Management LLC - MarketBeat
Compass Wealth Management LLC Acquires Shares of 16,715 Cigna Group $CI - MarketBeat
Cigna (CI) Faces Challenges with Proposed Medicare Rate Changes - GuruFocus
The Bull Case For Cigna Group (CI) Could Change Following FTC Pause Of PBM Case Proceedings - simplywall.st
Ending drug rebates will cost Cigna as much as $500M, CEO tells congressional panel - BenefitsPRO
Will FTC Settlement Pause for Express Scripts Reshape Cigna Group’s (CI) PBM-Driven Investment Narrative? - Yahoo Finance
Congress Grills Health Insurance CEOs With Hunterbrook Exposé - Hunterbrook
Cigna Group $CI Shares Sold by Resona Asset Management Co. Ltd. - MarketBeat
Cigna Group $CI Stock Position Raised by UniSuper Management Pty Ltd - MarketBeat
Strs Ohio Sells 9,232 Shares of Cigna Group $CI - MarketBeat
Commerzbank Aktiengesellschaft FI Has $5.01 Million Stock Position in Cigna Group $CI - MarketBeat
FTC Pause On Cigna PBM Case Highlights Valuation And Regulatory Risk - simplywall.st
Cigna Group $CI Shares Sold by AMF Tjanstepension AB - MarketBeat
Can The Cigna Group be the next market leaderJuly 2025 Review & AI Enhanced Execution Alerts - mfd.ru
TrueMark Investments LLC Acquires Shares of 19,890 Cigna Group $CI - MarketBeat
Cigna Group (NYSE:CI) Cut to Hold at Wall Street Zen - MarketBeat
A Look At Cigna Group (CI) Valuation As Evernorth And Recession Narrative Draw Fresh Investor Interest - simplywall.st
FTC Delays Drug Middlemen Case While Talks Move Forward - Benzinga
US health insurance executives testify before Congress about increasing costs of healthcare - The Guardian
5 ways prioritizing preventive care can protect your health and your wallet - Cigna Healthcare Newsroom
Teacher Retirement System of Texas Purchases 21,839 Shares of Cigna Group $CI - MarketBeat
Bernstein Maintains Cigna Group(CI.US) With Hold Rating, Maintains Target Price $307 - 富途资讯
Insurance CEO hearings: Takeaways from a long day on Capitol Hill - Modern Healthcare News
Cigna Group (NYSE:CI) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
RBC Capital Maintains Cigna Group(CI.US) With Buy Rating, Maintains Target Price $344 - 富途资讯
Cigna sees up to $600M earnings hit from ending drug rebates - Modern Healthcare News
Insurance CEO hearings: Execs endure criticism on costs, business practices - Modern Healthcare News
Brian Evanko on affordable, personalized healthcare - McKinsey & Company
Health insurance CEOs grilled on high costs of care in back-to-back House hearings - NBC News
House Health Insurance - timesargus.com
Cigna Sees Up to $600 Million Earnings Hit From Pharmacy Plan - Bloomberg
Commercial health insurer CEOs testify on health care affordability; AHA submits statements for House hearings - American Hospital Association
Health insurance execs shift blame for costly, confusing health care system - statnews.com
Watch live: Health insurance CEOs testify before House on rising premiums - The Hill
US lawmakers press health insurance executives on affordability - Reuters
UNH and CVS Face Congress Over Healthcare Affordability - Barron's
March 6th Options Now Available For The Cigna Group (CI) - Nasdaq
Rakuten Investment Management Inc. Acquires New Stake in Cigna Group $CI - MarketBeat
UnitedHealth CEO Says Hospitals, Drug Prices Drive US Health Care Costs, Pledges ACA Rebates - Benzinga
Wealth Enhancement Advisory Services LLC Has $27.84 Million Stock Holdings in Cigna Group $CI - MarketBeat
Health insurance CEOs to appear before House committees as premiums soar - NBC News
FTC, Cigna weigh insulin settlement - Modern Healthcare News
Birches Health Hires Ex-Cigna Leader as SVP of Strategy to Drive Payor-Integrated National Expansion - TipRanks
UnitedHealth plans to rebate exchange profits to customers - Modern Healthcare News
Cigna Group Stock (CI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):